Compare ALNY to:
Real-Time: 16.62 -0.16 (-0.95%) 1:02pm ET
| Last Trade: | 16.57 |
|---|---|
| Trade Time: | 12:51pm ET |
| Change: | |
| Prev Close: | 16.78 |
| Open: | 16.68 |
| Bid: | 16.56 x 100 |
| Ask: | 16.57 x 100 |
| 1y Target Est: | 26.17 |
| Day's Range: | 16.48 - 16.73 |
|---|---|
| 52wk Range: | 14.82 - 26.36 |
| Volume: | 86,754 |
| Avg Vol (3m): | 237,289 |
| Market Cap: | 692.87M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.19 |
| Div & Yield: | N/A (N/A) |
| Tue, Nov 24 | Alnylam to Webcast Presentation at Piper Jaffray 21st Annual Health Care ConferenceBusiness Wire |
| Tue, Nov 24 | Alnylam Pharma downgraded by Roth CapitalBriefing.com |
| Wed, Nov 18 | Alnylam Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver CancerBusiness Wire |
| Thu, Nov 12 | Alnylam Provides Update on RNAi Pipeline, Platform, and Technology at Its R&D DayBusiness Wire |
| Tue, Nov 10 | ALNYLAM PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials |
| Mon, Nov 9 | Alnylam to Webcast R&D Day on Thursday, November 12, 2009Business Wire |
| Thu, Nov 5 | Alnylam slips on Q3 loss, cautious outlookat bizjournals.com |
| Thu, Nov 5 | Biotech Stocks: BioCryst, Isis rally; Alnylam fallsat MarketWatch |
| Thu, Nov 5 | Biotech Stocks: Drug stocks gain; Alnylam slidesat MarketWatch |
| Thu, Nov 5 | New Star Analyst Rankings for Alnylam Pharmaceuticals, Inc.StarMine |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.